Press release
Pain Management Therapeutics Market to Exceed US$ 83 Billion by 2024
New York, February 16: Market Research Engine has published a new report titled as “Pain Management Therapeutics Market by Therapeutics Analysis (Antidepressants, Anesthetics, Anticonvulsants, Opioids (Oxycodones, Hydrocodones, Tramadol), Antimigraine Agents, Other Non-narcotic Analgesic); by Indication Analysis (Migraine, Cancer Pain, Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Post-operative Pain) - Global Industry Analysis and Forecast 2016 - 2024”How Big is The Pain Management Therapeutics Market?
The pain management therapeutics market is expected to exceed more than US$ 83 Billion by 2024; Growing at a CAGR of more than 3.5% in the given forecast period.
Browse Full Report: https://www.marketresearchengine.com/reportdetails/pain-management-therapeutics-market
Pain management is one of the branch of medicine which utilizes an inter punitive approach for improving the superiority and easing the suffering of life of persons who are living with the chronic pain. The usual pain management group consists of clinical psychologists, clinical nurse specialists, physician assistants, occupational therapists, physiotherapists, pharmacists and medical practitioners. Market analyst proposes that almost 20% of world’s population currently suffers from chronic pain. Factors that are increasing number of surgeries, changing lifestyle, increasing geriatric population and increasing prevalence of chronic diseases are responsible for growth in new patients every year.
The major driving factors of pain management therapeutics market are as follows:
Approving health care reforms and regulatory scenario
Increasing approval of pain management therapeutics between end users
Increasing in geriatric population with high risk of different diseases
Growing frequency of chronic pain disorders
The restraining factors of pain management therapeutics market are as follows:
Enduring pain relief from medical devices, alternative therapies and surgical procedures
Prescription drug exploitation
Exclusive rights expiry of entry of generics and key drugs
Download Free Sample Report: https://www.marketresearchengine.com/requestsample/pain-management-therapeutics-market
The pain management therapeutics market is segmented on the lines of its therapeutics, indication and regional. Based on therapeutics segmentation it covers antimigraine agents, non steroidal anti inflammatory drugs, anesthetics, antidepressants, anticonvulsants, opioids and other non narcotic analgesic. Opioidsis further segmented into tramadol, hydrocodones, oxycodaones and others such as methadone, meperidine, fentanyl, codeine, morphine. Based on indication segmentation the pain management therapeutics market covers cancer pain, post operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia and neuropathic pain. The pain management therapeutics marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for pain management therapeutics and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for pain management therapeutics.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for pain management therapeutics with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide buyers with a snapshot of the industry’s most influential players.
The Pain management therapeutics Market has been segmented as below:
By Therapeutics Analysis
Antimigraine agents
Non steroidal anti inflammatory drugs
Anesthetics
Antidepressants
Anticonvulsants
Opioids
Tramadol
Hydrocodones
Oxycodaones
Others (Methadone, Meperidine, Fentanyl, Codeine, Morphine)
Other non narcotic analgesic
By Indication Analysis
Cancer pain
Post operative pain
Migraine
Arthritic pain
Chronic back pain
Fibromyalgia
Neuropathic pain
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pain Management Therapeutics Market to Exceed US$ 83 Billion by 2024 here
News-ID: 440273 • Views: …
More Releases from Market Research Engine Report
3D Printing Materials Market is Expected to Exceed USD 1400 Million by 2020
The 3 D Printing Materials Market is segmented based on material type, form and application. The 3 D Printing Materials Market is segmented based on material type as Plastics, Metals, Ceramics, Others. The 3 D Printing Materials Market is segmented based on form as Filament, Powder, Liquid. The 3 D Printing Materials Market is segmented based on application as Aerospace & defense, Medical & dental, Automotive, Consumer Goods,…
Titanium Dioxide Market is Expected to Reach US$ 21 Billion by 2021
The global titanium dioxide market by application is segmented as paints & coatings, pulp & paper, plastics, cosmetics and other applications. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW).
Browse Full Report @: https://www.marketresearchengine.com/reportdetails/titanium-dioxide-market
How Big is the Global Titanium Dioxide Market?
Global titanium dioxide market was accounted USD 15.5 billion in 2015. The revenue of this market is anticipated to increase…
IoT Healthcare Market in North America is Expected to Grow at CAGR of 43% by 202 …
The IoT healthcare market is divided into technologies and services. The technologies segment is again analyzed by network technologies and applications technologies. The network technologies are further segmented to short range technologies and long-range technologies which are equally vital top form a connected ecosystem of healthcare. The service market is analyzed by consulting, integration and maintenance. The solution segment contributes to a majority part of the market.
Browse Full Report…
Nonalcoholic Steatohepatitis (NASH) Market is Expected to Cross US$ 20.0 Billion …
The Nonalcoholic Steatohepatitis market is segmented on the lines of its Therapeutics such as GFT505, Obeticholic Acid (INT-747) Simtuzumab and Liraglutide (Victoza)Vitamin EPioglitazonePlacebo. The Nonalcoholic Steatohepatitis market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Browse Full Report @: https://www.marketresearchengine.com/reportdetails/non-alcoholic-steatohepatitis-nash-market
How Big is the Global Nonalcoholic Steatohepatitis (NASH) Market?
Global Non-Alcoholic Steatohepatitis (NASH) market is expected to cross US$ 20.0 Billion by…
More Releases for Pain
Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,…
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big…
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy.
Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have…
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Global Post-operative Pain Management Market - Overview
Post-operative pain management is the most important part…
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in…
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and…
